Declining demand for printed materials and other products for medical institutions
First written in FY2021-Q3. 3 of 11 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025WorsenedAnnual report
「Although the subsidiary engaged in manufacturing and selling inserting machines posted lower revenue as demand reached a peak, higher revenue at the subsidiary engaged in printed materials for medical institutions and the contribution of overseas subsidiaries resulted in revenue of ¥1,860 million, up 55.0% year on year. In terms of earnings, despite contributions from overseas subsidiaries and continued efficiency initiatives within the group, operating loss was ¥26 million, compared with operating profit of ¥20 million in the previous fiscal year.」
Despite contributions from overseas subsidiaries and efficiency gains, the Other business turned from operating profit in the previous fiscal year to an operating loss of ¥26 million. - FY2025-H1RestatedAnnual report
「Although revenue expanded at the subsidiary engaged in printed materials for medical institutions, revenue at the subsidiary engaged in manufacturing and selling inserting machines struggled as demand reached a peak, resulting in revenue of ¥566 million, down 7.8% year on year. In terms of earnings, although the effects of initiatives to improve efficiency within the group were confirmed, they were insufficient to offset the impact of lower revenue at the above-mentioned subsidiary manufacturing inserting machines. Operating loss was ¥10 million, compared with operating profit of ¥17 million in the same period of the previous year.」
Although the effects of efficiency initiatives were confirmed, the Other business could not offset the decline in revenue at the subsidiary manufacturing inserting machines as demand reached a peak, and turned to an operating loss. - FY2025-Q1Efficiency gains confirmed, but revenue decline leads to a lossAnnual report
「Although the effects of group-wide efficiency initiatives, including the transfer of production functions at the subsidiary engaged in printed materials for medical institutions, were confirmed, they were insufficient to offset the impact of lower revenue at the above-mentioned subsidiary manufacturing inserting machines. Operating loss was ¥8 million, compared with operating profit of ¥15 million in the same period of the previous year.」
Efficiency gains, including the transfer of production functions, were confirmed, but could not offset the decline in revenue at the subsidiary manufacturing inserting machines, and the Other business turned from operating profit in the same period of the previous year to an operating loss. - FY2024AdvancedAnnual report
「Group-wide efficiency initiatives, including the transfer of production functions of a subsidiary engaged in printed materials for medical institutions, proved effective, resulting in operating income of ¥68 million, compared with ¥4 million in the previous consolidated fiscal year, an increase of ¥63 million.」
The recovery in revenue at the subsidiary engaged in printed materials for medical institutions and efficiency gains from the transfer of production functions increased operating profit in the Other business by ¥63 million. - FY2024-Q3AdvancedAnnual report
「Although revenue increased at the subsidiary engaged in printed materials for medical institutions, revenue declined at the subsidiary engaged in manufacturing and selling inserting machines and in the information systems business, resulting in revenue of ¥1,282 million, up 1.5% year on year. In terms of earnings, operating profit was ¥57 million, up 197.2% year on year, partly because group-wide efficiency initiatives, including the transfer of production functions for printed materials for medical institutions, proved effective.」
The recovery in revenue at the subsidiary engaged in printed materials for medical institutions and efficiency gains from the transfer of production functions drove a 197.2% year-on-year increase in operating profit in the Other business. - FY2024-Q2AdvancedAnnual report
「Although sales at the subsidiary engaged in printing materials for medical institutions recovered, the subsidiary engaged in manufacturing and selling inserting machines and the information systems business posted lower sales, resulting in net sales of ¥850 million, down 3.9% year on year. In terms of earnings, Group-wide restructuring efforts, including the transfer of production functions at the medical-institution printing subsidiary, proved effective, and operating profit was ¥35 million, up 308.7% year on year.」
Revenue recovered at the subsidiary engaged in printed materials for medical institutions, and operating profit improved as structural reforms, including the intra-group transfer of production functions, proved effective. - FY2024-Q1Revenue growth and elimination of prior-year expensesAnnual report
「Although the subsidiary engaged in printing materials for medical institutions increased sales, the subsidiary engaged in manufacturing and selling inserting machines and the information systems business posted lower sales, resulting in net sales of ¥462 million, down 1.7% year on year. In terms of earnings, the factors that had caused costs in the previous fiscal year, including the transfer of production functions and relocation of headquarters at the medical-institution printing subsidiary, were eliminated in the current fiscal year, and operating profit was ¥18 million, compared with ¥0 million in the previous fiscal year.」
The subsidiary engaged in printed materials for medical institutions increased revenue, while the cost factors incurred in the previous period, including the transfer of production functions and relocation of headquarters, were eliminated this period. - FY2023-Q3RestatedAnnual report
「As performance at the subsidiary engaged in manufacturing and selling inserting machines recovered, net sales were ¥1,264 million, up 25.3% year on year. In terms of earnings, temporary costs were incurred as a result of restructuring within the Group, including the transfer of production functions at the subsidiary engaged in printing materials for medical institutions, and operating profit was ¥19 million, down 44.4% year on year.」
At the subsidiary engaged in printed materials for medical institutions, structural reforms, including the transfer of production functions, and one-time expenses continue to weigh on operating profit. - FY2023-Q2Structural reforms continue, weighing on profitAnnual report
「At the subsidiary engaged in printed materials for medical institutions, operating profit was ¥8 million, down 77.5% year on year, due to one-time relocation and other expenses incurred as a result of structural reforms within the group, including the transfer of production functions.」
For the subsidiary engaged in printed materials for medical institutions, the focus has shifted from an explanation centered on declining demand to structural reforms, including the transfer of production functions, and the incurrence of one-time expenses. - FY2023-Q1Focus shifts from declining demand to structural reformAnnual report
「At a subsidiary engaged in printed materials for medical institutions, temporary relocation costs and other expenses were incurred as a result of structural reform within the Group, including the transfer of production functions」
For the subsidiary engaged in printed materials for medical institutions, the disclosure has shifted from lower revenue and profit due to declining demand to structural reforms involving the transfer of production functions and the incurrence of one-time expenses. - FY2021-Q3First statedAnnual report
「As the subsidiary engaged in printing materials for medical institutions was affected by the decline in demand caused by the COVID-19 pandemic, net sales were ¥1,259 million, down 4.9% year on year, and operating profit was ¥34 million, down 52.6%.」
For the first time, the company specifically described declining demand, lower revenue and lower profit at a subsidiary engaged in printed materials for medical institutions and other products, within the Other business.